The GSTM1 null-allele polymorphism is associated with reduced mitochondrial enzyme activity, decreased ability to detoxify compounds, increased level of reactive oxygen species, and increased risk of cancers [32–34], diabetes mellitus [35], and other diseases of aging [2,23–27], primarily among Caucasians [34]. The gene discussed is GSTM1; the disease is cancer.